Registration number: 04952659

Ryburn Pharmacy (Ripponden) Limited

Contents

Balance Sheet	1 to 2
Notes to the Unaudited Financial Statements	3 to 6

Ryburn Pharmacy (Ripponden) Limited

Balance Sheet

as at 31 January 2026

	Note	2026 £	2025 £
Fixed assets
Tangible assets	4	20,965	24,302
Current assets
Stocks		68,094	70,905
Debtors	5	154,910	141,770
Cash at bank and in hand		729,016	697,733
		952,020	910,408
Creditors: Amounts falling due within one year	6	(379,380)	(361,064)
Net current assets		572,640	549,344
Total assets less current liabilities		593,605	573,646
Provisions for liabilities		(3,152)	(3,314)
Net assets		590,453	570,332
Capital and reserves
Allotted, called up and fully paid share capital		100	100
Profit and loss account		590,353	570,232
Shareholders' funds		590,453	570,332

Registration number: 04952659

Ryburn Pharmacy (Ripponden) Limited

Balance Sheet

as at 31 January 2026 (continued)

For the financial year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 21 August 2026 and signed on its behalf by:
 

......................................... Mr J Lubera Director

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2026

1	General information

The company is a private company limited by shares incorporated in England within the United Kingdom.

The company's registration number is 04952659.

The address of its registered office is:
First Floor
Rosemount House
Huddersfield Road
Elland
West Yorkshire
HX5 0EE

The principal place of business is:
Hirst Wood
Ripponden
Sowerby Bridge
West Yorkshire
HX6 4BN

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2026 (continued)

2	Accounting policies (continued)

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have been transferred to the buyer.

Tax

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Tangible assets

Tangible assets are stated in the balance sheet at cost (or deemed cost), less any accumulated depreciation and accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Fixtures, fittings and equipment	15% per annum on a reducing balance basis and 33.33% per annum on a straight line basis
Leasehold property improvements	Straight line over the life of the lease

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2026 (continued)

2	Accounting policies (continued)

Leases

Rentals in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year was 12 (2025 - 12).

4	Tangible assets

	Leasehold property improvements £	Furniture, fittings and computer equipment  £	Total £
Cost
At 1 February 2025	97,911	57,967	155,878
Additions	-	2,385	2,385
Disposals	-	(1,139)	(1,139)
At 31 January 2026	97,911	59,213	157,124
Depreciation
At 1 February 2025	78,380	53,196	131,576
Charge for the year	4,940	782	5,722
Eliminated on disposal	-	(1,139)	(1,139)
At 31 January 2026	83,320	52,839	136,159
Net book value
At 31 January 2026	14,591	6,374	20,965
At 31 January 2025	19,531	4,771	24,302

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2026 (continued)

5

Debtors

Current	2026 £	2025 £
Trade debtors	111,742	111,109
Prepayments	24,551	10,852
Other debtors	18,617	19,809
	154,910	141,770

6

Creditors

	2026 £	2025 £
Due within one year
Trade creditors	189,553	182,463
Taxation and social security	3,436	2,148
Corporation tax liability	51,725	36,629
Accruals and deferred income	5,394	7,192
Other creditors	13,894	14,360
Directors' loan accounts	115,378	118,272
	379,380	361,064

7	Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £168,220 (2025 - £204,064). These financial commitments relate to non-cancellable operating leases and are payable over the remaining life of those leases.